Acute promyelocytic leukemia in children and adolescents Journal Article


Authors: Stein, E. M.; Tallman, M. S.
Article Title: Acute promyelocytic leukemia in children and adolescents
Abstract: Acute promyelocytic leukemia (APL) is a rare subtype of AML characterized by a reciprocal balanced translocation between chromosomes 15 and 17 that fuses the PML gene with the RARα gene and leads to the leukemic phenotype. Although best described in large clinical trials of adults, APL, like other forms of AML, also occurs in children. The positive outcome of children with APL mirrors the dramatic increase in survival seen in adults since the introduction of all-trans retinoic acid (ATRA). In this paper, we review the diagnosis of APL in children as well as large, retrospective, clinical trial data collected on pediatric APL. We also raise management issues and toxicities that are unique to children. © 2014 S. Karger AG, Basel.
Keywords: survival rate; gene translocation; genetics; mortality; review; antineoplastic agents; clinical trials as topic; antineoplastic agent; leukemia, promyelocytic, acute; drug combination; drug therapy, combination; promyelocytic leukemia; translocation, genetic; retinoic acid; clinical trial (topic); tretinoin; arsenic; humans; human
Journal Title: Acta Haematologica
Volume: 132
Issue: 3-4
ISSN: 0001-5792
Publisher: S. Karger AG  
Date Published: 2014-09-01
Start Page: 307
End Page: 312
Language: English
DOI: 10.1159/000365117
PUBMED: 25228556
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein
  2. Martin Stuart Tallman
    649 Tallman